MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/1060028015627467

Медицинская библиотека · The Annals of pharmacotherapy · 2016

Apremilast: A Novel Drug for Treatment of Psoriasis and Psoriatic Arthritis.

Haber Stacy L, Hamilton Sarah, Bank Mark, Leong Shi Yun, Pierce Evelyn

Сравнительное исследованиеСтатьяОбзорПеревод в очереди

Аннотация

OBJECTIVE

To review the pharmacology, efficacy, and safety of apremilast and determine its role relative to other agents in the treatment of psoriasis and psoriatic arthritis.

DATA SOURCES: A PubMed search (1946 to December 2015) using the terms apremilast and CC-10004 was conducted to identify relevant articles.

STUDY SELECTION AND DATA EXTRACTION: In vitro or in vivo evaluations of apremilast published in the English language were eligible for inclusion. Controlled clinical trials that involved psoriasis or psoriatic arthritis were selected for review.

DATA SYNTHESIS: Four trials were identified on the treatment of psoriasis. In those that involved doses of 30 mg twice daily, a significantly greater percentage of patients receiving apremilast (28.8% to 40.9%) compared with placebo (5.3% to 5.8%) achieved at least 75% improvement from baseline in Psoriasis Area and Severity Index score at 16 weeks. Two trials were identified on the treatment of psoriatic arthritis. In the one that involved a dose of 30 mg twice daily, a significantly greater percentage of patients receiving apremilast (38.1%) compared with placebo (19.0%) achieved the American College of Rheumatology criteria for 20% improvement at 16 weeks. In all trials, the drug had an acceptable safety profile, with the most common adverse effects of diarrhea, nausea, and headache.

CONCLUSIONS

Apremilast has a novel mechanism of action and is safe and effective for the management of psoriasis and psoriatic arthritis. At this time, apremilast should be reserved for patients unable to take disease-modifying antirheumatic drugs.

Для цитирования: Haber Stacy L, Hamilton Sarah, Bank Mark, Leong Shi Yun, Pierce Evelyn. Apremilast: A Novel Drug for Treatment of Psoriasis and Psoriatic Arthritis.. The Annals of pharmacotherapy. 2016. DOI: 10.1177/1060028015627467.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.